Guidelines give greater nod to use of combination conventional disease-modifying antirheumatic drugs (DMARDs) for rheumatoid arthritis, leave monotherapy with methotrexate as acceptable first-line treatment
Rheumatology Research Foundation Advances Studies in Inflammatory Arthritis
Disease Targeted Research Initiative may improve treatment, prevention of rheumatoid arthritis, other inflammatory diseases
EULAR 2013: Research Hints at Risk Factors for Rheumatoid Arthritis
Studies point to involvement of anti-CCP antibodies and citrullinated targets in the lungs and joints in the development of RA, and suggest an early therapeutic window for prevention
Complementary and Alternative Medicine Therapies May Benefit Patients with Rheumatoid Arthritis
Acupuncture, mind-body therapy, and Chinese and Tibetan medicine may relieve pain and other symptoms of RA
Coding Corner Question: August
Test your coding knowledge for a separate identifiable service billed for a patient with rheumatoid arthritis
Coding Corner Answer: August Coding Challenge
Coding for a a separate identifiable service billed for a patient with rheumatoid arthritis
ACR 2013 State-of-the-Art Clinical Symposium: What’s Next in Therapy for Osteoarthritis, Rheumatoid Arthritis, and Lupus?
Experts highlight treatment advances and challenges ahead in OA, RA, and systemic lupus erythematosus (SLE)
B-Cell Genes Interact to Increase Risk for Rheumatoid Arthritis
Researchers demonstrate that BANK1 is a susceptibility gene for RA, and it may play a role in RA pathogenesis. (posted June 31, 2013)
California Rheumatology Alliance 2013 Meeting: Aim for Remission in Rheumatoid Arthritis
Early diagnosis and aggressive treatment of RA is key, expert says
California Rheumatology Alliance 2013 Meeting: The Future of Rheumatoid Arthritis
Treatment for RA should involve targeting subclinical disease and reversing immune dysregulation, expert says
- « Previous Page
- 1
- …
- 21
- 22
- 23
- 24
- 25
- …
- 45
- Next Page »